HomeEKTA-B • STO
Follow
Elekta AB (publ)
Previous close
kr 75.85
Day range
kr 74.50 - kr 76.40
Year range
kr 70.00 - kr 90.42
Market cap
27.64B SEK
Avg Volume
1.04M
P/E ratio
20.04
Dividend yield
3.20%
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jan 2024info | Y/Y change |
|---|---|---|
Revenue | 4.54B | 4.61% |
Operating expense | 1.06B | -0.84% |
Net income | 305.00M | 41.20% |
Net profit margin | 6.72 | 34.94% |
Earnings per share | 0.88 | 6.02% |
EBITDA | 766.00M | 3.93% |
Effective tax rate | 21.99% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jan 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.35B | 93.10% |
Total assets | 30.73B | 9.87% |
Total liabilities | 20.48B | 11.65% |
Total equity | 10.25B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.83 | — |
Return on assets | 4.88% | — |
Return on capital | 8.80% | — |
Cash Flow
Net change in cash
| (SEK) | Jan 2024info | Y/Y change |
|---|---|---|
Net income | 305.00M | 41.20% |
Cash from operations | 1.07B | 376.44% |
Cash from investing | -513.00M | -20.71% |
Cash from financing | 30.00M | 130.61% |
Net change in cash | 483.00M | 252.37% |
Free cash flow | 333.50M | 177.72% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,584
